71 related articles for article (PubMed ID: 1975260)
1. A novel approach to the generation of high affinity class II-binding peptides.
Sette A; Sidney J; Albertson M; Miles C; Colón SM; Pedrazzini T; Lamont AG; Grey HM
J Immunol; 1990 Sep; 145(6):1809-13. PubMed ID: 1975260
[TBL] [Abstract][Full Text] [Related]
2. Effect of conformational propensity of peptide antigens in their interaction with MHC class II molecules. Failure to document the importance of regular secondary structures.
Sette A; Lamont A; Buus S; Colon SM; Miles C; Grey HM
J Immunol; 1989 Aug; 143(4):1268-73. PubMed ID: 2787362
[TBL] [Abstract][Full Text] [Related]
3. The use of peptide analogs with improved stability and MHC binding capacity to inhibit antigen presentation in vitro and in vivo.
Lamont AG; Powell MF; Colón SM; Miles C; Grey HM; Sette A
J Immunol; 1990 Apr; 144(7):2493-8. PubMed ID: 2319129
[TBL] [Abstract][Full Text] [Related]
4. Structural analysis of peptides capable of binding to more than one Ia antigen.
Sette A; Buus S; Colon S; Miles C; Grey HM
J Immunol; 1989 Jan; 142(1):35-40. PubMed ID: 2535860
[TBL] [Abstract][Full Text] [Related]
5. Effect of pH on MHC class II-peptide interactions.
Sette A; Southwood S; O'Sullivan D; Gaeta FC; Sidney J; Grey HM
J Immunol; 1992 Feb; 148(3):844-51. PubMed ID: 1730877
[TBL] [Abstract][Full Text] [Related]
6. Primary in vivo responses to ovalbumin. Probing the predictive value of the Kb binding motif.
Lipford GB; Hoffman M; Wagner H; Heeg K
J Immunol; 1993 Feb; 150(4):1212-22. PubMed ID: 7679422
[TBL] [Abstract][Full Text] [Related]
7. I-Ak polymorphisms define a functionally dominant region for the presentation of hen egg lysozyme peptides.
Rosloniec EF; Vitez LJ; Beck BN; Buerstedde JM; McKean DJ; Landais D; Benoist C; Mathis D; Freed JH
J Immunol; 1989 Jul; 143(1):50-8. PubMed ID: 2786533
[TBL] [Abstract][Full Text] [Related]
8. Structural requirements for the interaction between peptide antigens and I-Ed molecules.
Sette A; Adorini L; Appella E; Colón SM; Miles C; Tanaka S; Ehrhardt C; Doria G; Nagy ZA; Buus S
J Immunol; 1989 Nov; 143(10):3289-94. PubMed ID: 2809202
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the interaction of peptide hen egg white lysozyme (34-45) with the I-Ak molecule.
Lambert LE; Unanue ER
J Immunol; 1989 Aug; 143(3):802-7. PubMed ID: 2787347
[TBL] [Abstract][Full Text] [Related]
10. Interference with the binding of a naturally processed peptide to class II alters the immunodominance of T cell epitopes in vivo.
Nikcevich KM; Kopielski D; Finnegan A
J Immunol; 1994 Aug; 153(3):1015-26. PubMed ID: 7517970
[TBL] [Abstract][Full Text] [Related]
11. The importance of dominant negative effects of amino acid side chain substitution in peptide-MHC molecule interactions and T cell recognition.
Boehncke WH; Takeshita T; Pendleton CD; Houghten RA; Sadegh-Nasseri S; Racioppi L; Berzofsky JA; Germain RN
J Immunol; 1993 Jan; 150(2):331-41. PubMed ID: 8093457
[TBL] [Abstract][Full Text] [Related]
12. I-Ad-binding peptides derived from unrelated protein antigens share a common structural motif.
Sette A; Buus S; Colon S; Miles C; Grey HM
J Immunol; 1988 Jul; 141(1):45-8. PubMed ID: 2837512
[TBL] [Abstract][Full Text] [Related]
13. Molecular analysis of the same HIV peptide functionally binding to both a class I and a class II MHC molecule.
Takeshita T; Takahashi H; Kozlowski S; Ahlers JD; Pendleton CD; Moore RL; Nakagawa Y; Yokomuro K; Fox BS; Margulies DH
J Immunol; 1995 Feb; 154(4):1973-86. PubMed ID: 7530749
[TBL] [Abstract][Full Text] [Related]
14. Peptide affinity for MHC influences the phenotype of CD8(+) T cells primed in vivo.
Ma H; Kapp JA
Cell Immunol; 2001 Nov; 214(1):89-96. PubMed ID: 11902833
[TBL] [Abstract][Full Text] [Related]
15. Kinetics and specificity of peptide-MHC class II complex displacement reactions.
de Kroon AI; McConnell HM
J Immunol; 1994 Jan; 152(2):609-19. PubMed ID: 8283041
[TBL] [Abstract][Full Text] [Related]
16. Nature of the ligand recognized by a hapten- and carrier-specific, MHC-restricted T cell receptor.
Nalefski EA; Rao A
J Immunol; 1993 May; 150(9):3806-16. PubMed ID: 7682584
[TBL] [Abstract][Full Text] [Related]
17. Use of global amino acid replacements to define the requirements for MHC binding and T cell recognition of moth cytochrome c (93-103).
Reay PA; Kantor RM; Davis MM
J Immunol; 1994 Apr; 152(8):3946-57. PubMed ID: 7511662
[TBL] [Abstract][Full Text] [Related]
18. Invariant chain can bind MHC class II at a site other than the peptide binding groove.
Wilson NA; Wolf P; Ploegh H; Ignatowicz L; Kappler J; Marrack P
J Immunol; 1998 Nov; 161(9):4777-84. PubMed ID: 9794409
[TBL] [Abstract][Full Text] [Related]
19. The inability of the nonobese diabetic class II molecule to form stable peptide complexes does not reflect a failure to interact productively with DM.
Peterson M; Sant AJ
J Immunol; 1998 Sep; 161(6):2961-7. PubMed ID: 9743359
[TBL] [Abstract][Full Text] [Related]
20. Identification from a phage display library of peptides that bind to toxic shock syndrome toxin-1 and that inhibit its binding to major histocompatibility complex (MHC) class II molecules.
Sato A; Ida N; Fukuyama M; Miwa K; Kazami J; Nakamura H
Biochemistry; 1996 Aug; 35(32):10441-7. PubMed ID: 8756700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
